NEW YORK (GenomeWeb News) – Oxford Nanopore has raised £17.4 million ($28 million) in a new round of funding through existing and new investors and its marketing partner Illumina UK.

The firm is developing a nanopore-based, single-molecule sequencing platform and said that it will use the funds to accelerate development of the technology. It also said that it would use funds to support its lead project in DNA sequencing and to start early work in protein analysis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: human cytomegalovirus diversity, patterns of homologous recombination in E. coli, and more.

US lawmakers are considering eliminating the medical devices tax that is part of the Affordable Care Act.

Two research teams in China home in on a gene that gives rice a long, slender shape.

Marcia McNutt, the editor-in-chief of Science, has been nominated to become president of the US National Academy of Sciences.

Jul
14
Sponsored by
Agilent Technologies

This online seminar will outline a recent example of the use of molecular barcoding in combination with next-generation sequencing to detect somatic mosaicism in cancer patients.